Insulet Corporation announced the appointment of Eric Benjamin to Chief Operating Officer, effective immediately. In this expanded role, Mr. Benjamin will lead Insulet’s end-to-end growth and innovation engine, overseeing Strategy & Business Development, the Office of the Chief Technology Officer, Research & Development, and a newly-created Growth organization.
The company also appointed Manoj Raghunandanan as Chief Growth Officer. Mr. Raghunandanan brings over 20 years of global consumer health leadership experience from Kenvue (formerly Johnson & Johnson Consumer Health). He will lead Insulet’s newly-formed Growth organization, focusing on global strategy, demand generation, commercial excellence, and stewarding the global brand and customer experience.
These executive appointments strengthen Insulet's leadership team and signal a strategic focus on accelerating growth and innovation. Elevating Eric Benjamin to COO centralizes key growth functions, while the addition of Manoj Raghunandanan as Chief Growth Officer brings deep global consumer health expertise. These changes are designed to enhance Insulet's ability to seize new market opportunities and drive its next chapter of global expansion and impact.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.